Quarterly Transactions Made in Monte Rosa Therapeutics, Inc. (GLUE)
This table provides information about the institutional ownership of Monte Rosa Therapeutics, Inc. (GLUE). The information is specifically focused on institutions that hold shares of Monte Rosa Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 4,516,999 | 889,016 | 5,406,015 | 653,862 | 1,709,041 | 2,362,903 | 3,043,112 | |
| Q4 2021 | 1,888,903 | 245,727 | 2,134,630 | 232,717 | 290,265 | 522,982 | 1,611,648 | |
| Q1 2022 | 4,664,189 | 359,769 | 5,023,958 | 32,669 | 1,307,198 | 1,339,867 | 3,684,091 | |
| Q2 2022 | 839,099 | 186,340 | 1,025,439 | 2,159,634 | 164,891 | 2,324,525 | -1,299,086 | |
| Q3 2022 | 1,645,232 | 2,387,473 | 4,032,705 | 2,423,927 | 0 | 2,423,927 | 1,608,778 | |
| Q4 2022 | 1,661,541 | 148,871 | 1,810,412 | 391,510 | 0 | 391,510 | 1,418,902 | |
| Q1 2023 | 346,773 | 843,425 | 1,190,198 | 866,050 | 0 | 866,050 | 324,148 | |
| Q2 2023 | 4,561,051 | 378,193 | 4,939,244 | 1,742,746 | 0 | 1,742,746 | 3,196,498 | |
| Q3 2023 | 2,279,681 | 146,312 | 2,425,993 | 837,370 | 0 | 837,370 | 1,588,623 | |
| Q4 2023 | 1,469,729 | 466,638 | 1,936,367 | 2,373,684 | 0 | 2,373,684 | -437,317 | |
| Q1 2024 | 556,148 | 221,985 | 778,133 | 859,579 | 0 | 859,579 | -81,446 | |
| Q2 2024 | 2,611,149 | 4,075,528 | 6,686,677 | 678,626 | 0 | 678,626 | 6,008,051 | |
| Q3 2024 | 2,898,990 | 1,183,884 | 4,082,874 | 600,749 | 16,338 | 617,087 | 3,465,787 | |